CREATE Medicines Appoints Allan L. Shaw as Chief Financial Officer and Chief Business Officer
Position
Chief Financial Officer
Company
CREATE Medicines
CambridgeBiotechnologyHealth CareTherapeuticsDescription
CREATE Medicines announced the appointment of Allan L Shaw as Chief Financial Officer and Chief Business Officer. Mr Shaw will oversee the company's financial strategy and business development initiatives as they expand their clinical and commercial ambitions.
Quick answer
CREATE Medicines Appoints Allan L. Shaw as Chief Financial Officer and Chief Business Officer (October 8, 2025). CREATE Medicines is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Financial Officer at CREATE Medicines?
- CREATE Medicines named Allan L. Shaw Chief Financial Officer, announced October 8, 2025.
- What did CREATE Medicines announce on October 8, 2025?
- CREATE Medicines announced the appointment of Allan L Shaw as Chief Financial Officer and Chief Business Officer. Mr Shaw will oversee the company's financial strategy and business development initiatives as they expand their clinical and commercial ambitions.
- What does CREATE Medicines do?
- CREATE Medicines is a clinical-stage biotech pioneering in vivo multi-immune programming.
- Where is CREATE Medicines based?
- CREATE Medicines is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Cartesian Therapeutics, Inc. (October 8, 2025), Qualigen Therapeutics (October 6, 2025), BPGbio (October 6, 2025) and Atossa Therapeutics (October 14, 2025) also announced leadership changes within 45 days of CREATE Medicines.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cartesian Therapeutics Appoints June Seymour as Chief Accounting Officer (October 8, 2025)
- Qualigen Therapeutics Appoints Jerry Wang as Co-CEO and Koti Meka as CFO (October 6, 2025)
- BPGbio Appoints Brian Berman as Interim Chief Medical Officer (October 6, 2025)
- Atossa Therapeutics Appoints Mark Daniel as Chief Financial Officer (October 14, 2025)
- Fate Therapeutics Appoints Kamal Adawi as Chief Financial Officer (October 14, 2025)
- Libra Therapeutics Promotes Martin Gill, Ph.D. to Chief Scientific Officer (October 15, 2025)
Who to call at CREATE Medicines, and when
A new leader at CREATE Medicines brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day CREATE Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CREATE Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CREATE Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CREATE Medicines changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CREATE Medicines changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.